Building on our strong capabilities in chemical development and manufacturing, Laurus Labs has developed an in-house range of APIs and related intermediates. Focusing on chemistries where we can make a difference, Laurus combined innovation with efficiency by developing cost effective processes while simultaneously investing in suitable capacities to ensure reliability of supply.
Laurus is one of the world’s leading suppliers of anti-retroviral APIs & intermediates and we believe our low cost technologies in this critical segment will help increase access to medicine for those in need throughout the world. Laurus works closely with leading innovators, global health organizations and providers to ensure cost reduction targets are met without compromising quality standards.
With state-of-the-art facilities to handle highly potent materials at both developmental and commercial scale, Laurus considers Oncology one of its core competencies and offers a comprehensive range of APIs in this segment.
Laurus offers its globally compliant cGMP facilities, along with its chemistry expertise and experience, to its customers for contract development and manufacturing of APIs and intermediates.
With proven capabilities to meet and exceed the clients’ requirements in terms of quality, regulatory and IP needs as well as cost targets, Laurus Labs aims to provide a total API solution to the global market.
Laurus is continuously extending its portfolio to include focus on molecules in other therapy areas where it feels it can establish a leading position.